metformin has been researched along with Gastroesophageal Reflux in 5 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Gastroesophageal Reflux: Retrograde flow of gastric juice (GASTRIC ACID) and/or duodenal contents (BILE ACIDS; PANCREATIC JUICE) into the distal ESOPHAGUS, commonly due to incompetence of the LOWER ESOPHAGEAL SPHINCTER.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Chemoprevention in Barrett's esophagus is currently applied only in research settings." | 2.52 | Chemoprevention in Barrett's Esophagus: Current Status. ( Baruah, A; Buttar, NS; Kossak, SK; Zeb, MH, 2015) |
| "Gastrointestinal discomfort is the most common adverse event of metformin treatment for type 2 diabetes, especially in elderly patients." | 1.56 | Comparison of gastrointestinal adverse events with different doses of metformin in the treatment of elderly people with type 2 diabetes. ( Cuiping, J; Haidong, W; Jiao, S; Jieyuzhen, Q; Qin, G; Wen, T; Xiaoming, T; Yuxin, H; Zhijun, B, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yuxin, H | 1 |
| Cuiping, J | 1 |
| Wen, T | 1 |
| Jieyuzhen, Q | 1 |
| Xiaoming, T | 1 |
| Qin, G | 1 |
| Haidong, W | 1 |
| Jiao, S | 1 |
| Zhijun, B | 1 |
| Inci, F | 1 |
| Atmaca, M | 1 |
| Ozturk, M | 1 |
| Yildiz, S | 1 |
| Koceroglu, R | 1 |
| Sekeroglu, R | 1 |
| Ipekci, SH | 1 |
| Kebapcilar, L | 1 |
| Zeb, MH | 1 |
| Baruah, A | 1 |
| Kossak, SK | 1 |
| Buttar, NS | 1 |
| Taylor, SA | 1 |
| Himes, R | 1 |
| Hastings, E | 1 |
| Garland, B | 1 |
| Boehm, KM | 1 |
| Gunaga, S | 1 |
2 reviews available for metformin and Gastroesophageal Reflux
| Article | Year |
|---|---|
Chemoprevention in Barrett's Esophagus: Current Status.
Topics: Adenocarcinoma; Anti-Inflammatory Agents, Non-Steroidal; Barrett Esophagus; Bile Acids and Salts; Cy | 2015 |
Gastrointestinal Conditions in the Obese Patient.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Anti-Obesity Agents; Constipation; Contraceptiv | 2016 |
3 other studies available for metformin and Gastroesophageal Reflux
| Article | Year |
|---|---|
Comparison of gastrointestinal adverse events with different doses of metformin in the treatment of elderly people with type 2 diabetes.
Topics: Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; China; Diabetes Mellitus, Type 2; | 2020 |
Pantoprazole may improve beta cell function and diabetes mellitus.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Ulcer Agents; Cohort Studies; | 2014 |
Cimetidine-induced lactic acidosis and acute pancreatitis.
Topics: Acidosis, Lactic; Acute Disease; Cimetidine; Diabetes Mellitus, Type 2; Drug Interactions; Female; G | 2010 |